Menopause

New data presented at the European Society for Paediatric Endocrinology virtual meeting revealed that exposure to bisphenols, phthalates and perfluoroalkyl substances can increase the risk for obesity.

The cause of midlife migraines in women is likely multifactorial, though research suggests that fluctuating hormone levels may play a role, according to a speaker at the North American Menopause Society annual meeting.

Menopausal hormone therapy is safe and effective for many women experiencing bothersome symptoms like hot flashes, but treatment should be individualized for people with certain risk factors, according to a speaker.

In this video, NAMS medical director Stephanie Faubion, MD, discusses highlights from her presentation at the organization’s annual meeting on nonhormone therapies currently being investigated for the management of vasomotor symptoms.

A speaker at the North American Menopause Society Annual Meeting told attendees that menopause-related sleep fragmentation may negatively impact mood, metabolism and daytime wellbeing. It was the top story in endocrinology last week.

Women with sedentary lifestyles face a greater risk for experiencing hot flashes at night, according to a study presented at the North American Menopause Society Annual Meeting.

An investigational nonhormonal therapy for moderate to severe hot flashes significantly reduced symptom frequency at 12 weeks compared with placebo, with improvements observed as early as 1 week after treatment, data from SKYLIGHT 2 show.

Menopause-related sleep fragmentation has downstream effects on mood, daytime wellbeing and metabolism, even when women meet recommended guidelines for normal sleep duration, according to a speaker.

Estrogen dosage, the type of formulation and the number of years since menopause may alter a woman’s risk for hypertension, according to data from the Women’s Health Initiative Observational Study published in Menopause.

New research showed that absolute appendicular lean mass may help predict osteoporosis in postmenopausal women. It was the top story in endocrinology last week.